The effect of growth hormone on the metabolome of follicular fluid in patients with diminished ovarian reserve

被引:9
作者
He, Fan [1 ,2 ,3 ]
Wang, Fang [4 ]
Yang, Yang [5 ]
Yuan, Zhi [1 ]
Sun, Chengguang [1 ,2 ]
Zou, Heng [1 ,2 ]
Chen, Huijia [1 ,2 ]
Yi, Hongliang [1 ,2 ]
Gao, Shan Hu [6 ]
Zhang, Shen [1 ,2 ]
Hu, Lina [1 ,2 ,3 ]
Han, Ting-li [1 ,2 ,6 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Ctr Reprod Med, Obstet & Gynecol Dept, Chongqing 400010, Peoples R China
[2] Chongqing Med Univ, Joint Int Res Lab Reprod & Dev, Minist Educ, Chongqing 400010, Peoples R China
[3] Reprod & Stem Cell Therapy Res Ctr Chongqing, Chongqing 400010, Peoples R China
[4] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Sch Med, Dept Reprod & Infertil, Chengdu 611731, Peoples R China
[5] Chongqing Med Univ, Affiliated Hosp 1, Obstet Dept, Chongqing 400042, Peoples R China
[6] Chongqing Med Univ, Mass Spectrometry Ctr Maternal Fetal Med, Chongqing 400010, Peoples R China
基金
中国国家自然科学基金;
关键词
Growth hormone; Diminished ovarian reserve; Follicular fluid; Metabolomics; Gas chromatograph-mass spectrometry; IN-VITRO FERTILIZATION; OOCYTE QUALITY; OXIDATIVE STRESS; GRANULOSA-CELLS; WOMEN; STIMULATION; MECHANISMS; RESPONDERS; PROFILE; DEATH;
D O I
10.1186/s12958-023-01073-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIncreasing evidence supports that the co-treatment with growth hormone (GH) enhances ovarian response and oocyte quality during controlled ovarian stimulation (COS) in patients with diminished ovarian reserve (DOR). The composition of follicular fluid (FF) plays an essential role in oocyte development and mirrors the communication occurring between the oocyte and follicular microenvironment. However, the effect of GH on the FF metabolome remains unclear.MethodsThis prospective observational study recruited DOR patients undergoing in vitro fertilization (IVF) cycles with minimal stimulation protocol for COS. Each patient receiving GH co-treatment was matched to a patient without GH co-treatment by propensity score matching. The FF was collected after isolating oocytes and assayed by gas chromatograph-mass spectrometry (GC-MS) metabolomics. The Pearson correlation was performed to evaluate the relationship between the number of oocytes retrieved and the levels of differential metabolites. The KEGG database was used to map differential metabolites onto various metabolic pathways.ResultsOne hundred thirty-four FF metabolites were identified by GC-MS metabolomics. Twenty-four metabolites, including glutathione, itaconic acid and S-adenosylmethionin (SAM) showed significant differences between the GH and control groups (p-value < 0.05 and q-value < 0.1). In addition, the number of oocytes retrieved was significantly higher in the GH group compared to the control group (3 vs 2, p = 0.04) and correlated with the levels of five differential metabolites. Among them, the levels of antioxidant metabolite itaconic acid were upregulated by GH administration, while SAM levels were downregulated.ConclusionsThe co-treatment with GH during COS may improve oocyte development by altering FF metabolite profiles in DOR patients. However, given the downregulation of SAM, a regulator of genomic imprinting, the potential risk of imprinting disturbances should not be neglected.
引用
收藏
页数:11
相关论文
共 58 条
  • [1] Growth hormone and its receptor in human ovaries from fetuses and adults
    Abir, Ronit
    Garor, Roni
    Felz, Carmela
    Nitke, Shmuel
    Krissi, Haim
    Fisch, Benjamin
    [J]. FERTILITY AND STERILITY, 2008, 90 : 1333 - 1339
  • [2] Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients
    Battaglia, C
    Salvatori, M
    Maxia, N
    Petraglia, F
    Facchinetti, F
    Volpe, A
    [J]. HUMAN REPRODUCTION, 1999, 14 (07) : 1690 - 1697
  • [3] Growth hormone alters components of the glutathione metabolic pathway in Ames dwarf mice
    Brown-Borg, HM
    Rakoczy, SG
    Uthus, EO
    [J]. STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF AGING MAY BE FORESEEABLE, 2004, 1019 : 317 - 320
  • [4] Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis
    Busnelli, Andrea
    Somigliana, Edgardo
    Cirillo, Federico
    Levi-Setti, Paolo Emanuele
    [J]. HUMAN REPRODUCTION UPDATE, 2021, 27 (06) : 973 - 988
  • [5] The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection Treatment: A Retrospective Study Based on POSEIDON Criteria
    Cai, Mei-hong
    Gao, Lin-zhi
    Liang, Xiao-Yan
    Fang, Cong
    Wu, Yao-qiu
    Yang, Xing
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [6] Egg Quality and Pregnancy Outcome in Young Infertile Women with Diminished Ovarian Reserve
    Chang, Yajie
    Li, Jingjie
    Li, Xiaolan
    Liu, Hong'e
    Liang, Xiaoyan
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 7279 - 7284
  • [7] Diminished ovarian reserve, premature ovarian failure, poor ovarian responder-a plea for universal definitions
    Cohen, J.
    Chabbert-Buffet, N.
    Darai, E.
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2015, 32 (12) : 1709 - 1712
  • [8] Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury
    Cordes, Thekla
    Lucas, Alfredo
    Divakaruni, Ajit S.
    Murphy, Anne N.
    Cabrales, Pedro
    Metallo, Christian M.
    [J]. MOLECULAR METABOLISM, 2020, 32 : 122 - 135
  • [9] Targeted metabolomics reveals reduced levels of polyunsaturated choline plasmalogens and a smaller dimethylarginine/arginine ratio in the follicular fluid of patients with a diminished ovarian reserve
    de la Barca, J. M. Chao
    Boueilh, T.
    Simard, G.
    Boucret, L.
    Ferre-L'Hotellier, V.
    Tessier, L.
    Gadras, C.
    Bouet, P. E.
    Descamps, P.
    Procaccio, V.
    Reynier, P.
    May-Panloup, P.
    [J]. HUMAN REPRODUCTION, 2017, 32 (11) : 2269 - 2278
  • [10] Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System
    Devine, Kate
    Mumford, Sunni L.
    Wu, Mae
    DeCherney, Alan H.
    Hill, Micah J.
    Propst, Anthony
    [J]. FERTILITY AND STERILITY, 2015, 104 (03) : 612 - +